# Sekhmet Pharmaventures jobs and careers

> 0 open roles at Sekhmet Pharmaventures as of October 23, 2026. Source: https://www.thejobsmap.com/company/sekhmet-pharmaventures

Sekhmet Pharmaventures Pvt. Ltd. (part of Gamot API Pte Ltd. based in Singapore). Asian private equity major PAG has formed an investment platform called Gamot API Pte. Ltd. based in Singapore, along with Indian private equity firms, CX Partners and Samara Capital, to buy stakes in fast-growing pharma companies. Gamot API is led by PAG as a majority partner. The Indian arm of Gamot API is known as Sekhmet Pharmaventures Pvt. Ltd. The platform made its first investment by acquiring a controlling stake in Chennai-based Anjan Drug Pvt. Ltd. in October 2020. The second investment in the Optimus Drugs Group of Companies has been finalized in Sept 2022. The Company plans to invest in multiple manufacturing facilities dedicated to Active Pharmaceutical Ingredients and formulations, as India is expected to become an important part of the global supply chain, amid changing geopolitical dynamics.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | India |
| Founded | 2020 |
| Employees | 350 |
| Industries | Manufacturing, Pharmaceutical |
| Website | https://sekhmetpharma.com |

## Leadership

- Santosh Mahil, MD&CEO

## Common questions

### Is Sekhmet Pharmaventures hiring right now?

Sekhmet Pharmaventures has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Sekhmet Pharmaventures's careers site.

### Where is Sekhmet Pharmaventures headquartered?

Sekhmet Pharmaventures is headquartered in India and was founded in 2020.

### Who leads Sekhmet Pharmaventures?

Santosh Mahil, MD&CEO, is at the top of Sekhmet Pharmaventures's org chart.

### How do I apply for a job at Sekhmet Pharmaventures?

Pick a role on Sekhmet Pharmaventures's TheJobsMap page and select Apply. Every listing links to the original posting on Sekhmet Pharmaventures's own careers site, so you apply directly with the employer.